These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 18333908)
1. 2007 IXA Presidential Address. Progress toward an ideal source animal: opportunities and challenges in a changing world. Sykes M Xenotransplantation; 2008 Feb; 15(1):7-13. PubMed ID: 18333908 [TBL] [Abstract][Full Text] [Related]
2. The first Joint Conference of the Cell Transplant Society (CTS), International Pancreas and Islet Transplant Association (IPITA), and International Xenotransplantation Association (IXA), all sections of The Transplantation Society (TTS), took place in Minneapolis, Minn, USA, from September 15-20, 2007. Preface. Hering BJ; Sykes M; Sutherland DE; Shapiro AM; Tremblay JP Transplant Proc; 2008 Mar; 40(2):335-6. PubMed ID: 18374060 [No Abstract] [Full Text] [Related]
3. Abstracts of the Joint Meeting of the International Xenotransplantation Association (IXA), the International Pancreas and Islet Transplant Association (IPITA), and the Cell Transplant Society (CTS), Minneapolis, Minnesota, USA, September 15-20, 2007. Xenotransplantation; 2007 Sep; 14(5):375-549. PubMed ID: 17803509 [No Abstract] [Full Text] [Related]
4. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 1: update on national regulatory frameworks pertinent to clinical islet xenotransplantation. Cozzi E; Tönjes RR; Gianello P; Bühler LH; Rayat GR; Matsumoto S; Park CG; Kwon I; Wang W; O'Connell P; Jessamine S; Elliott RB; Kobayashi T; Hering BJ Xenotransplantation; 2016; 23(1):14-24. PubMed ID: 26940509 [TBL] [Abstract][Full Text] [Related]
5. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework. Cozzi E; Tallacchini M; Flanagan EB; Pierson RN; Sykes M; Vanderpool HY Xenotransplantation; 2009; 16(4):203-14. PubMed ID: 19799760 [TBL] [Abstract][Full Text] [Related]
7. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria. Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763 [TBL] [Abstract][Full Text] [Related]
8. Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell Replacement. Markmann JF; Bartlett ST; Johnson P; Korsgren O; Hering BJ; Scharp D; Kay TW; Bromberg J; Odorico JS; Weir GC; Bridges N; Kandaswamy R; Stock P; Friend P; Gotoh M; Cooper DK; Park CG; OʼConnell PJ; Stabler C; Matsumoto S; Ludwig B; Choudhary P; Khovatchev B; Rickels MR; Sykes M; Wood K; Kraemer K; Hwa A; Stanley E; Ricordi C; Zimmerman M; Greenstein J; Montanya E; Otonkoski T Transplantation; 2016 Jul; 100(7):e25-31. PubMed ID: 27082827 [TBL] [Abstract][Full Text] [Related]
9. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Executive summary. Hering BJ; Cozzi E; Spizzo T; Cowan PJ; Rayat GR; Cooper DK; Denner J Xenotransplantation; 2016; 23(1):3-13. PubMed ID: 26940725 [TBL] [Abstract][Full Text] [Related]
11. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 6: Patient selection for pilot clinical trials of islet xenotransplantation. O'Connell PJ Xenotransplantation; 2009; 16(4):249-54. PubMed ID: 19799765 [TBL] [Abstract][Full Text] [Related]
13. Current status and future of clinical islet xenotransplantation. Matsumoto S; Tomiya M; Sawamoto O J Diabetes; 2016 Jul; 8(4):483-93. PubMed ID: 26987992 [TBL] [Abstract][Full Text] [Related]
14. International human xenotransplantation inventory. Sgroi A; Bühler LH; Morel P; Sykes M; Noel L Transplantation; 2010 Sep; 90(6):597-603. PubMed ID: 20644502 [TBL] [Abstract][Full Text] [Related]
15. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials. Vanderpool HY Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766 [TBL] [Abstract][Full Text] [Related]
16. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing. Korbutt GS Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762 [TBL] [Abstract][Full Text] [Related]
18. Immunological Challenges Facing Translation of Alginate Encapsulated Porcine Islet Xenotransplantation to Human Clinical Trials. Krishnan R; Ko D; Foster CE; Liu W; Smink AM; de Haan B; De Vos P; Lakey JR Methods Mol Biol; 2017; 1479():305-333. PubMed ID: 27738946 [TBL] [Abstract][Full Text] [Related]
19. Xenotransplantation: from the lab to the clinic: Sunrise Symposium at the XXIII International Congress of the Transplantation Society, Vancouver, Canada, August 2010. Schuurman HJ Clin Transplant; 2011; 25(4):E415-21. PubMed ID: 21535153 [TBL] [Abstract][Full Text] [Related]
20. [Islet cell and pancreas transplantation in diabetes: status 1996]. Bretzel RG Ther Umsch; 1996 Dec; 53(12):889-901. PubMed ID: 9036567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]